CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

by | Jun 24, 2026 | Health

Spread the love
Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments